| Document Date: 2008-06-09 00:50:15
Open Document File Size: 29,41 KBShare Result on Facebook
City Newark / New York / Paris / Princeton / Lausanne / Bridgewater / / Company Sanofi-Aventis / SANOFI-AVENTIS U.S. LLC / Defendant Sandoz Inc. / SANDOZ INC. / DEBIOPHARM S.A. / 21 Sanofi-Aventis U.S. LLC / McCARTER & ENGLISH LLP / SanofiAventis / and DEBIOPHARM S.A. / / Country Switzerland / France / United States / / Event FDA Phase / M&A / Patent Issuance / / Facility Rockefeller Plaza / United States District Court / / IndustryTerm generic pharmaceutical products / life-saving pharmaceuticals / proposed generic drug product / proposed drug products / innovator pharmaceutical / manufacturing / generic oxaliplatin solution / treatment of colorectal cancer / generic oxaliplatin products / innovator healthcare / oxaliplatin solution / / MedicalCondition colorectal cancer / cancers / cardiovascular disease / diseases / / Organization United States District Court for the District of New Jersey / United States Food and Drug Administration / / Person Shaughnessy William / Dominick Conde / Robert L. Baechtold / Peter D. Shapiro / Jonathan M.H. Short / William E. Solander / / / Position attorney / Counsel / HARPER / owner of United States Patent No. / / Product Eloxatin / Abbreviated New Drug Application / Eloxatin® / / ProvinceOrState New Jersey / New York / Delaware / NEW JERSEY William J. O’Shaughnessy / Colorado / /
SocialTag |
Case 3:08-cv[removed]JAP-JJH Document 1 Filed[removed]